These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 17470479)

  • 1. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience.
    Al-Toma A; Verbeek WH; Hadithi M; von Blomberg BM; Mulder CJ
    Gut; 2007 Oct; 56(10):1373-8. PubMed ID: 17470479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring nonresponsive patients who have celiac disease.
    Krauss N; Schuppan D
    Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma.
    Mulder CJ; Wahab PJ; Moshaver B; Meijer JW
    Scand J Gastroenterol Suppl; 2000; (232):32-7. PubMed ID: 11232488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical staging and survival in refractory celiac disease: a single center experience.
    Rubio-Tapia A; Kelly DG; Lahr BD; Dogan A; Wu TT; Murray JA
    Gastroenterology; 2009 Jan; 136(1):99-107; quiz 352-3. PubMed ID: 18996383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease.
    Verbeek WH; Goerres MS; von Blomberg BM; Oudejans JJ; Scholten PE; Hadithi M; Al-Toma A; Schreurs MW; Mulder CJ
    Clin Immunol; 2008 Jan; 126(1):48-56. PubMed ID: 18024205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased circulating iNKT cell numbers in refractory coeliac disease.
    Bernardo D; van Hoogstraten IM; Verbeek WH; Peña AS; Mearin ML; Arranz E; Garrote JA; Scheper RJ; Schreurs MW; Bontkes HJ; Mulder CJ; von Blomberg BM
    Clin Immunol; 2008 Feb; 126(2):172-9. PubMed ID: 17974485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization.
    Verbeek WH; von Blomberg BM; Coupe VM; Daum S; Mulder CJ; Schreurs MW
    Cytometry B Clin Cytom; 2009 Nov; 76(6):367-74. PubMed ID: 19444812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma.
    Al-Toma A; Goerres MS; Meijer JW; Peña AS; Crusius JB; Mulder CJ
    Clin Gastroenterol Hepatol; 2006 Mar; 4(3):315-9. PubMed ID: 16527694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience.
    Nasr I; Nasr I; Beyers C; Chang F; Donnelly S; Ciclitira PJ
    Nutrients; 2015 Dec; 7(12):9896-907. PubMed ID: 26633478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease.
    Hadithi M; Mallant M; Oudejans J; van Waesberghe JH; Mulder CJ; Comans EF
    J Nucl Med; 2006 Oct; 47(10):1622-7. PubMed ID: 17015897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refractory coeliac disease.
    Daum S; Cellier C; Mulder CJ
    Best Pract Res Clin Gastroenterol; 2005 Jun; 19(3):413-24. PubMed ID: 15925846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in refractory coeliac disease: a review.
    Ho-Yen C; Chang F; van der Walt J; Mitchell T; Ciclitira P
    Histopathology; 2009 Jun; 54(7):783-95. PubMed ID: 18700844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cladribine therapy in refractory celiac disease with aberrant T cells.
    Al-Toma A; Goerres MS; Meijer JW; von Blomberg BM; Wahab PJ; Kerckhaert JA; Mulder CJ
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1322-7; quiz 1300. PubMed ID: 16979946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MYO9B gene is a strong risk factor for developing refractory celiac disease.
    Wolters VM; Verbeek WH; Zhernakova A; Onland-Moret C; Schreurs MW; Monsuur AJ; Verduijn W; Wijmenga C; Mulder CJ
    Clin Gastroenterol Hepatol; 2007 Dec; 5(12):1399-405, 1405.e1-2. PubMed ID: 17967566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azathioprine and prednisone combination therapy in refractory coeliac disease.
    Goerres MS; Meijer JW; Wahab PJ; Kerckhaert JA; Groenen PJ; Van Krieken JH; Mulder CJ
    Aliment Pharmacol Ther; 2003 Sep; 18(5):487-94. PubMed ID: 12950421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell repertoires in refractory coeliac disease.
    Ritter J; Zimmermann K; Jöhrens K; Mende S; Seegebarth A; Siegmund B; Hennig S; Todorova K; Rosenwald A; Daum S; Hummel M; Schumann M
    Gut; 2018 Apr; 67(4):644-653. PubMed ID: 28188172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Approach to patients with refractory coeliac disease.
    Nasr I; Nasr I; Campling H; Ciclitira PJ
    F1000Res; 2016; 5():. PubMed ID: 27803799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Jejunal ulcerations - a diagnostic challenge in a patient with coeliac disease].
    Weber M; Schumann M; Felber J; Mireskandari M; Schmidt C; Stallmach A
    Z Gastroenterol; 2015 Nov; 53(11):1261-6. PubMed ID: 26562400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of complicated celiac disease.
    Al-toma A; Verbeek WH; Mulder CJ
    Dig Dis; 2007; 25(3):230-6. PubMed ID: 17827946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of Enteropathy-Associated T Cell Lymphoma.
    Chander U; Leeman-Neill RJ; Bhagat G
    Curr Hematol Malig Rep; 2018 Aug; 13(4):308-317. PubMed ID: 29943210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.